212 related articles for article (PubMed ID: 29117755)
1. Contribution of oxidative stress in acute intestinal mucositis induced by 5 fluorouracil (5-FU) and its pro-drug capecitabine in rats.
Rtibi K; Selmi S; Grami D; Amri M; Sebai H; Marzouki L
Toxicol Mech Methods; 2018 May; 28(4):262-267. PubMed ID: 29117755
[TBL] [Abstract][Full Text] [Related]
2. Puerarin Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Mice by Inhibiting JAKs.
Wang L; Song B; Hu Y; Chen J; Zhang S; Chen D; Wang J
J Pharmacol Exp Ther; 2021 Nov; 379(2):147-155. PubMed ID: 34400527
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress.
Zeeshan M; Atiq A; Ain QU; Ali J; Khan S; Ali H
Inflammopharmacology; 2021 Oct; 29(5):1539-1553. PubMed ID: 34420176
[TBL] [Abstract][Full Text] [Related]
4. L-arginine pretreatment reduces intestinal mucositis as induced by 5-FU in mice.
Leocádio PC; Antunes MM; Teixeira LG; Leonel AJ; Alvarez-Leite JI; Machado DC; Generoso SV; Cardoso VN; Correia MI
Nutr Cancer; 2015; 67(3):486-93. PubMed ID: 25803482
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice.
Gou H; Gu LY; Shang BZ; Xiong Y; Wang C
Hum Exp Toxicol; 2016 Dec; 35(12):1243-1251. PubMed ID: 26801985
[TBL] [Abstract][Full Text] [Related]
6. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents.
Atiq A; Shal B; Naveed M; Khan A; Ali J; Zeeshan S; Al-Sharari SD; Kim YS; Khan S
Eur J Pharmacol; 2019 Jan; 843():292-306. PubMed ID: 30529194
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of 5-fluorouracil-induced intestinal mucositis in rats by vitamin E via targeting oxidative stress and inflammatory markers.
Al-Asmari AK; Khan AQ; Al-Asmari SA; Al-Rawi A; Al-Omani S
J Complement Integr Med; 2016 Dec; 13(4):377-385. PubMed ID: 27682716
[TBL] [Abstract][Full Text] [Related]
8. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.
Justino PF; Melo LF; Nogueira AF; Morais CM; Mendes WO; Franco AX; Souza EP; Ribeiro RA; Souza MH; Soares PM
Cancer Chemother Pharmacol; 2015 Mar; 75(3):559-67. PubMed ID: 25572363
[TBL] [Abstract][Full Text] [Related]
9. Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury.
Zhang S; Liu Y; Xiang D; Yang J; Liu D; Ren X; Zhang C
Biomed Pharmacother; 2018 Oct; 106():910-916. PubMed ID: 30119262
[TBL] [Abstract][Full Text] [Related]
10. Oral Administration of Polaprezinc Attenuates Fluorouracil-induced Intestinal Mucositis in a Mouse Model.
Liu Z; Xie W; Li M; Teng N; Liang X; Zhang Z; Yang Z; Wang X
Basic Clin Pharmacol Toxicol; 2017 Dec; 121(6):480-486. PubMed ID: 28667794
[TBL] [Abstract][Full Text] [Related]
11. Treatment with selenium-enriched Saccharomyces cerevisiae UFMG A-905 partially ameliorates mucositis induced by 5-fluorouracil in mice.
Porto BAA; Monteiro CF; Souza ÉLS; Leocádio PCL; Alvarez-Leite JI; Generoso SV; Cardoso VN; Almeida-Leite CM; Santos DA; Santos JRA; Nicoli JR; Pessione E; Martins FS
Cancer Chemother Pharmacol; 2019 Jul; 84(1):117-126. PubMed ID: 31079219
[TBL] [Abstract][Full Text] [Related]
12. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.
Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS
Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190
[TBL] [Abstract][Full Text] [Related]
13. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model.
Ali J; Khan AU; Shah FA; Ali H; Islam SU; Kim YS; Khan S
Life Sci; 2019 Dec; 239():116888. PubMed ID: 31639401
[TBL] [Abstract][Full Text] [Related]
14. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
[TBL] [Abstract][Full Text] [Related]
15. Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis.
Saegusa Y; Ichikawa T; Iwai T; Goso Y; Ikezawa T; Nakano M; Shikama N; Saigenji K; Ishihara K
Scand J Gastroenterol; 2008; 43(5):531-7. PubMed ID: 18415744
[TBL] [Abstract][Full Text] [Related]
16. Protective effect and potential mechanisms of Wei-Chang-An pill on high-dose 5-fluorouracil-induced intestinal mucositis in mice.
Chen Y; Zheng H; Zhang J; Wang L; Jin Z; Gao W
J Ethnopharmacol; 2016 Aug; 190():200-11. PubMed ID: 27240747
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of royal jelly on methotrexate-induced systemic oxidative stress and damage to small intestine in rats.
Kaynar L; Cetin A; Hacioglu SK; Eser B; Koçyigit İ; Canöz Ö; Tasdemir A; Karadag C; Kurnaz F; Saraymen R; Silici S
Afr J Tradit Complement Altern Med; 2012; 9(3):412-7. PubMed ID: 23983375
[TBL] [Abstract][Full Text] [Related]
18. Patchouli oil ameliorates 5-fluorouracil-induced intestinal mucositis in rats via protecting intestinal barrier and regulating water transport.
Gan Y; Ai G; Wu J; Luo H; Chen L; Huang Q; Wu X; Xu N; Li M; Su Z; Liu Y; Huang X
J Ethnopharmacol; 2020 Mar; 250():112519. PubMed ID: 31883475
[TBL] [Abstract][Full Text] [Related]
19. A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine.
Eskandari MR; Moghaddam F; Shahraki J; Pourahmad J
Xenobiotica; 2015 Jan; 45(1):79-87. PubMed ID: 25034007
[TBL] [Abstract][Full Text] [Related]
20. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
Soares PM; Lima-Junior RC; Mota JM; Justino PF; Brito GA; Ribeiro RA; Cunha FQ; Souza MH
Cancer Chemother Pharmacol; 2011 Sep; 68(3):713-20. PubMed ID: 21153821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
